Login | Register

Kadcyla For Late-Stage Breast Cancer Approved By FDA

Kadcyla (ado-trastuzumab emtansine), a new medication for the treatment of HER2-positive, metastatic breast cancer, has been approved by the Food and Drug Administration (FDA), USA. Metastatic, also known as late-stage, means the cancer has spread to other parts of the body...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *